Giesecke+Devrient Continues Strong Growth Trajectory
Giesecke+Devrient (G+D) continues to write its growth story. The SecurityTech company achieved the highest revenue in its history in the 2024 fiscal year, surpassing its outstanding 2023 performance, even in an economically challenging environment.
The SecurityTech company G+D continued its growth path in the past fiscal year 2024. The company generated revenue of EUR 3.132 billion, achieving organic revenue growth of five percent compared to the previous year, or six percent at constant exchange rates. In the previous fiscal year 2023, the G+D Group achieved sales of just under three billion euros for the first time.
G+D's earning power also reached a new peak. Adjusted earnings before interest and taxes (EBIT) increased by 6% to 187 million euros. Free cash flow improved to over 200 million euros. The company's order intake suggests that this growth trajectory is set to continue, amounting to a record volume of 3.3 billion euros.
G+D's future-proof portfolio proved to be a strong driver of business success in challenging economic times. Across its three segments – Digital Security, Financial Platforms and Currency Technology – the SecurityTech group offers integrated security technology that closely links digital and physical solutions. With this portfolio, it strengthens the trust of citizens and consumers in the digital age and is actively shaping the digital transformation of our society.
From its strong foundation, G+D is continuously working to improve its profitability, optimize processes and leverage synergies. At the same time, the company is making targeted investments in its IT infrastructure and portfolio. With its three robust segments and resilient portfolio, G+D is well positioned for the future. It is, therefore, confident about the 2025 fiscal year and anticipates continued sales growth.
"Our strategic transformation is yielding positive results”, explains Ralf Wintergerst, Chairman of the Management Board and Group CEO of Giesecke+Devrient. “We are continuing our growth story and will also continue to make targeted investments. SecurityTech is one of the major growth industries of the future".
About Giesecke+Devrient
Giesecke+Devrient (G+D) is a global SecurityTech company headquartered in Munich, Germany. The company shapes trust in the digital age, with built-in security technology in three segments: Digital Security, Financial Platforms and Currency Technology.
G+D was founded in 1852 and today has a workforce of more than 14,000 employees. In 2024, the company generated a turnover of 3.1 billion euros. Website: www.gi-de.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250402599137/en/
Contacts
Nicole Oehl, nicole.oehl@pr-com.de
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Geoquip Marine Secures €100million Bond to Accelerate Fleet Enhancements and Strategic Growth4.4.2025 10:00:00 EEST | Press release
Geoquip Marine (Geoquip), a global leader in offshore geotechnical solutions and a Njord Partners portfolio company, is pleased to announce today it has successfully closed a €100million bond offering. This bond issuance significantly improves the Company’s cash balance, supports its continued growth, and is seen as a significant step in the Company’s ongoing maturation and development. The bond was placed after a successful roadshow with investors and will be used to advance key strategic initiatives. The immediate use of proceeds will be allocated between the repayment of existing debt and funding for two transformational projects: The Geoquip Silvretta: As announced in December, Geoquip Silvretta is currently in a shipyard in Norway undergoing work to create a state-of-the-art geotechnical services platform for the offshore energy sector. The vessel is on track to start operations in the first half of 2025. The Geoquip Elena: The Company is preparing to install a rig on Geoquip Elen
SES Announces Annual General Meeting Voting Results4.4.2025 09:50:00 EEST | Press release
SES S.A. (“SES” or the “Company”) held the Company’s Annual General Meeting (“AGM”) at its headquarters in Betzdorf, Luxembourg, yesterday. The shareholders have voted all resolutions in accordance with the recommendations made by SES’s Board of Directors, notably the company’s 2024 annual accounts and the proposed annual dividend of EUR 0.50 per A-share (EUR 0.20 per B-share). The total amount includes the interim dividend of EUR 0.25 per A-share (EUR 0.10 per B-share) already paid to shareholders on 17 October 2024. The final dividend of EUR 0.25 per A-share (EUR 0.10 per B-share) will be paid to shareholders on 17 April 2025. Also as recommended by the Board of Directors, the shareholders approved the appointments of Mrs Ellen Lord and Mr John Shaw to the Board of Directors and the non-binding agenda item received from Atlas Infrastructure Partners regarding capital returns. “The outcome of the AGM is the result of SES’s ongoing commitment to productive shareholder engagement, ensur
ENHERTU ® Approved in the EU as First HER2 Directed Therapy for Patients with HR Positive, HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following at Least One Endocrine Therapy4.4.2025 09:00:00 EEST | Press release
Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 low (IHC 1+ or IHC 2+/ISH-) or HER2 ultralow (IHC 0 with membrane staining) breast cancer who have received at least one endocrine therapy in the metastatic setting and who are not considered suitable for endocrine therapy as the next line of treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca. The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the DESTINY-Breast06 phase 3 trial presented at the 2024 American Society of Clinical Oncology (#
Western Union Offers Zero-Fee International Money Transfers to Myanmar4.4.2025 04:00:00 EEST | Press release
In response to the devastating earthquake that recently struck Myanmar, Western Union today announced that it is offering consumers around the world zero-fee international money transfers1 to the country. Effective immediately until midnight, 00:00 Myanmar Standard Time on 10 April 2025, individuals can send funds to Myanmar via WesternUnion.com or the Western Union mobile app, ensuring families can provide crucial support to their loved ones during this time of urgent need. Western Union remains committed to providing support during times of crisis, offering zero-fee transfers whenever possible to help communities in need. Money transfers sent to Myanmar will be: Available for payout into bank accounts. Available for payout into select mobile wallets Available for payouts incash at Agent locations2 “Our thoughts are with the people of Myanmar during this incredibly difficult time,” said Atish Shrestha, Western Union’s Regional Director for Indochina, South Korea and Taiwan, Western Un
Clean Tech Leader Aymium Defeats Stora Enso at European Patent Office Boards of Appeal4.4.2025 01:07:00 EEST | Press release
Cleantech leader Aymium defeated a challenge by Stora Enso to one of Aymium's patents (European Patent EP2697185) that provides exclusive rights to produce, sell and use bio-based materials for renewable battery applications. In its written opinion, the Boards of Appeal of the European Patent Office found Stora Enso's arguments brought before the board “not convincing” and agreed that a clarifying amendment to the claims did not extend the scope of protection of the patent. The ruling further affirms Aymium's position as the global leader in biocarbon materials for battery applications. Beyond the present ruling, Aymium owns a portfolio of more than 600 patents relating to biocarbon materials, compositions and manufacturing methods, including many specifically relevant to battery materials, and is the dominant global innovator regarding biocarbon materials. The ruling, combined with Aymium's massive patent portfolio, calls into question the ability of Stora Enso to produce bio-based ba
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom